Effects of Avelumab Maintenance on Advanced Urothelial Carcinoma: A Real‐World Multicenter Study
Avelumab maintenance appeared to improve outcomes across cycles 2-3 and ≥ 4, though residual confounding cannot be excluded.
Authors
- Shingo Hatakeyama (ORCID: https://orcid.org/0000-0002-0026-4079)
- Tomonori Habuchi (ORCID: https://orcid.org/0000-0003-0998-4432)
- Mizuki Kobayashi (ORCID: https://orcid.org/0000-0002-4135-6789)
- Kazuyuki Numakura (ORCID: https://orcid.org/0000-0002-5899-1738)
- Teppei Okamoto (ORCID: https://orcid.org/0000-0002-3750-3811)
- Jotaro Mikami
- Naoki Fujita (ORCID: https://orcid.org/0000-0001-8284-9582)
- Ryuji Tabata
- Satoshi Sato (ORCID: https://orcid.org/0000-0003-0459-4128)
- Masanao Shinohara (ORCID: https://orcid.org/0000-0003-1327-509X)
- Takahiro Yoneyama (ORCID: https://orcid.org/0000-0003-1061-827X)
- Yuya Sekine
- Chikara Οhyama (ORCID: https://orcid.org/0000-0003-1550-8379)
- Noritaka Ishii
- Kanami Mori
- Yohei Kawashima
Institutions
- Hirosaki University (JP)
- Akita University (JP)
- Aomori Rosai Hospital (JP)
- Hakodate Central General Hospital (JP)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cam4.71241
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00